Trial · NCT04999020
Participant flow32
How many started, completed or left each group, period by period.
1 to 20 of 32
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Randomized Controlled Period (RCP) | STARTED | RCP: Ravulizumab | 26 | |
| Randomized Controlled Period (RCP) | STARTED | RCP: Placebo | 12 | |
| Randomized Controlled Period (RCP) | STARTED | OLE: Ravulizumab to Ravulizumab | 0 | |
| Randomized Controlled Period (RCP) | STARTED | OLE: Placebo to Ravulizumab | 0 | |
| Randomized Controlled Period (RCP) | Received at Least 1 Dose of Treatment | RCP: Ravulizumab | 26 | |
| Randomized Controlled Period (RCP) | Received at Least 1 Dose of Treatment | RCP: Placebo | 12 | |
| Randomized Controlled Period (RCP) | Received at Least 1 Dose of Treatment | OLE: Ravulizumab to Ravulizumab | 0 | |
| Randomized Controlled Period (RCP) | Received at Least 1 Dose of Treatment | OLE: Placebo to Ravulizumab | 0 | |
| Randomized Controlled Period (RCP) | COMPLETED | RCP: Ravulizumab | 22 | |
| Randomized Controlled Period (RCP) | COMPLETED | RCP: Placebo | 9 | |
| Randomized Controlled Period (RCP) | COMPLETED | OLE: Ravulizumab to Ravulizumab | 0 | |
| Randomized Controlled Period (RCP) | COMPLETED | OLE: Placebo to Ravulizumab | 0 | |
| Randomized Controlled Period (RCP) | NOT COMPLETED | RCP: Ravulizumab | 4 | |
| Randomized Controlled Period (RCP) | NOT COMPLETED | RCP: Placebo | 3 | |
| Randomized Controlled Period (RCP) | NOT COMPLETED | OLE: Ravulizumab to Ravulizumab | 0 | |
| Randomized Controlled Period (RCP) | NOT COMPLETED | OLE: Placebo to Ravulizumab | 0 | |
| Open-Label Extension (OLE) Period | STARTED | RCP: Ravulizumab | 0 | |
| Open-Label Extension (OLE) Period | STARTED | RCP: Placebo | 0 | |
| Open-Label Extension (OLE) Period | STARTED | OLE: Ravulizumab to Ravulizumab | 22 | |
| Open-Label Extension (OLE) Period | STARTED | OLE: Placebo to Ravulizumab | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04999020/flow